IRS1 and Insulin resistance: Insulin resistance, chronic inflammation, oxidative damage, and dyslipidemia are generally characterized by the activation of the IRS1/PI3K/AKT pathway, particularly, this being the route activated by insulin or insulin-like growth factor 1 (IGF-1) in insulin resistance [55].